Using EU GMP Annex 22 as the Framework for Governing AI Systems, Validation Traceability, and Data Integrity Controls
Learn how to apply EU GMP Annex 22 as a practical framework for AI system governance, validation traceability, lifecycle management, and data integrity controls in regulated pharmaceutical and biotech environments.
Instructor
Charles H. Paul
President, CHP Consulting LLC — Regulatory Compliance & Operational Excellence
What You'll Learn
About the event
About this event
Artificial Intelligence is transforming how regulated organizations manage quality systems, manufacturing operations, compliance activities, and business processes. AI-enabled technologies now support activities ranging from document generation and data analysis to predictive maintenance, process optimization, quality investigations, and decision support. As adoption accelerates, regulatory expectations regarding governance, validation, traceability, and data integrity continue to evolve.
This webinar examines the practical implications of EU GMP expectations as they relate to AI systems operating within regulated environments. Participants will explore how traditional GMP principles intersect with emerging AI technologies and how organizations can establish governance structures that maintain compliance while supporting innovation.
The session focuses on the unique challenges associated with validating AI-enabled systems. Unlike traditional software applications, AI models may demonstrate adaptive behavior, rely on large training datasets, generate probabilistic outputs, and require ongoing monitoring throughout their operational lifecycle. Participants will learn how validation traceability can be established and maintained despite these complexities and how organizations can create evidence demonstrating continued fitness for intended use.
Special attention will be given to data integrity considerations, including training data governance, source data reliability, auditability, model transparency, output verification, electronic records management, and change control requirements.
The webinar will also address governance structures necessary to support AI implementation, including roles and responsibilities, lifecycle management practices, risk assessment methodologies, performance monitoring programs, retraining controls, and inspection readiness activities.
Code: FDB1608
Curriculum
Requirements
- Working in EU GMP-regulated pharmaceutical, biotechnology, medical device, or advanced therapy environments
- Applicable to QA, validation, IT, digital transformation, regulatory affairs, and compliance professionals
Who Should Attend
Quality Assurance Directors, Quality Systems Managers, GMP Compliance Professionals, Validation Managers, Computer System Validation Specialists, Digital Transformation Leaders, Manufacturing Directors, Operations Directors, Regulatory Affairs Professionals, Data Integrity Specialists, IT Quality Managers, Automation Engineers, Quality Risk Management Leaders, Internal Auditors, AI Governance Teams, Compliance Consultants, and Executive Leadership Teams.
Areas Covered
Meet Your Instructor

Charles H. Paul
President, CHP Consulting LLC — Regulatory Compliance & Operational Excellence
Charles H. Paul is President of CHP Consulting LLC, a regulatory compliance, operational excellence, training, and technical documentation consulting firm supporting pharmaceutical, biotechnology, medical device, and advanced therapy organizations worldwide. With more than 30 years of experience in regulated manufacturing environments, Charles specializes in helping organizations build sustainable quality systems that support compliance, operational performance, workforce effectiveness, and inspection readiness.
Event Details
Format
Recorded Webinar
Duration
1 hour
Certificate
Included
Access
Lifetime
Related Events
Digital Quality Metrics and AI/ML Analytics: Building a Continuous-Improvement Framework that Aligns with Regulatory Expectations
Learn how AI/ML and real-time digital quality metrics build a continuous-improvement framework aligned with FDA regulatory expectations, 21 CFR Part 11, and GAMP®5.

AI in GMP: What the FDA Is Already Expecting - Before You Ask
FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.

HPLC Analytical Method Development and Validation
Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.